Annual Retained Earnings
-$323.04 M
-$116.05 M-56.06%
September 30, 2024
Summary
- As of February 8, 2025, ENTA annual retained earnings is -$323.04 million, with the most recent change of -$116.05 million (-56.06%) on September 30, 2024.
- During the last 3 years, ENTA annual retained earnings has fallen by -$371.62 million (-765.02%).
- ENTA annual retained earnings is now -297.29% below its all-time high of $163.74 million, reached on September 30, 2019.
Performance
ENTA Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$323.04 M
-$28.82 M-9.80%
September 30, 2024
Summary
- As of February 8, 2025, ENTA quarterly retained earnings is -$323.04 million, with the most recent change of -$28.82 million (-9.80%) on September 30, 2024.
- Over the past year, ENTA quarterly retained earnings has dropped by -$116.05 million (-56.06%).
- ENTA quarterly retained earnings is now -282.32% below its all-time high of $177.18 million, reached on December 31, 2019.
Performance
ENTA Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
ENTA Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -56.1% | -56.1% |
| 3 y3 years | -765.0% | -765.0% |
| 5 y5 years | -297.3% | -765.0% |
ENTA Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -765.0% | at low | -1849.8% | at low |
| 5 y | 5-year | -297.3% | at low | -282.3% | at low |
| alltime | all time | -297.3% | at low | -282.3% | at low |
Enanta Pharmaceuticals Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | -$323.04 M(+56.1%) | -$323.04 M(+9.8%) |
| Jun 2024 | - | -$294.22 M(+8.3%) |
| Mar 2024 | - | -$271.56 M(+13.0%) |
| Dec 2023 | - | -$240.40 M(+16.1%) |
| Sep 2023 | -$207.00 M(+182.9%) | -$207.00 M(+15.7%) |
| Jun 2023 | - | -$178.89 M(+27.9%) |
| Mar 2023 | - | -$139.82 M(+36.9%) |
| Dec 2022 | - | -$102.17 M(+39.6%) |
| Sep 2022 | -$73.18 M(-250.6%) | -$73.18 M(+56.3%) |
| Jun 2022 | - | -$46.83 M(+209.5%) |
| Mar 2022 | - | -$15.13 M(-182.0%) |
| Dec 2021 | - | $18.46 M(-62.0%) |
| Sep 2021 | $48.58 M(-61.9%) | $48.58 M(-33.6%) |
| Jun 2021 | - | $73.17 M(-24.7%) |
| Mar 2021 | - | $97.20 M(-18.5%) |
| Dec 2020 | - | $119.24 M(-6.5%) |
| Sep 2020 | $127.57 M(-22.1%) | $127.57 M(-18.7%) |
| Jun 2020 | - | $156.91 M(-8.3%) |
| Mar 2020 | - | $171.18 M(-3.4%) |
| Dec 2019 | - | $177.18 M(+8.2%) |
| Sep 2019 | $163.74 M(+39.5%) | $163.74 M(+5.9%) |
| Jun 2019 | - | $154.55 M(+4.8%) |
| Mar 2019 | - | $147.51 M(+2.9%) |
| Dec 2018 | - | $143.37 M(+22.2%) |
| Sep 2018 | $117.36 M | $117.36 M(+30.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2018 | - | $89.94 M(+29.1%) |
| Mar 2018 | - | $69.65 M(+22.0%) |
| Dec 2017 | - | $57.09 M(+25.9%) |
| Sep 2017 | $45.36 M(+64.1%) | $45.36 M(+412.6%) |
| Jun 2017 | - | $8.85 M(-48.8%) |
| Mar 2017 | - | $17.27 M(-23.8%) |
| Dec 2016 | - | $22.67 M(-18.0%) |
| Sep 2016 | $27.65 M(+362.3%) | $27.65 M(-6.1%) |
| Jun 2016 | - | $29.45 M(-3.5%) |
| Mar 2016 | - | $30.52 M(-5.1%) |
| Dec 2015 | - | $32.17 M(+437.9%) |
| Sep 2015 | $5.98 M(-108.2%) | $5.98 M(+3459.5%) |
| Jun 2015 | - | $168.00 K(-107.5%) |
| Mar 2015 | - | -$2.25 M(-92.7%) |
| Dec 2014 | - | -$31.00 M(-57.5%) |
| Sep 2014 | -$73.01 M(-32.1%) | -$73.01 M(+7.4%) |
| Jun 2014 | - | -$67.97 M(-42.4%) |
| Mar 2014 | - | -$118.02 M(+4.6%) |
| Dec 2013 | - | -$112.82 M(+5.0%) |
| Sep 2013 | -$107.45 M(-6.9%) | -$107.45 M(+4.3%) |
| Jun 2013 | - | -$103.01 M(+4.2%) |
| Mar 2013 | - | -$98.87 M(+4.8%) |
| Dec 2012 | - | -$94.35 M(-18.2%) |
| Sep 2012 | -$115.37 M(-12.6%) | -$115.37 M(+4.6%) |
| Jun 2012 | - | -$110.28 M(-16.4%) |
| Sep 2011 | -$131.97 M | -$131.97 M |
FAQ
- What is Enanta Pharmaceuticals annual retained earnings?
- What is the all time high annual retained earnings for Enanta Pharmaceuticals?
- What is Enanta Pharmaceuticals annual retained earnings year-on-year change?
- What is Enanta Pharmaceuticals quarterly retained earnings?
- What is the all time high quarterly retained earnings for Enanta Pharmaceuticals?
- What is Enanta Pharmaceuticals quarterly retained earnings year-on-year change?
What is Enanta Pharmaceuticals annual retained earnings?
The current annual retained earnings of ENTA is -$323.04 M
What is the all time high annual retained earnings for Enanta Pharmaceuticals?
Enanta Pharmaceuticals all-time high annual retained earnings is $163.74 M
What is Enanta Pharmaceuticals annual retained earnings year-on-year change?
Over the past year, ENTA annual retained earnings has changed by -$116.05 M (-56.06%)
What is Enanta Pharmaceuticals quarterly retained earnings?
The current quarterly retained earnings of ENTA is -$323.04 M
What is the all time high quarterly retained earnings for Enanta Pharmaceuticals?
Enanta Pharmaceuticals all-time high quarterly retained earnings is $177.18 M
What is Enanta Pharmaceuticals quarterly retained earnings year-on-year change?
Over the past year, ENTA quarterly retained earnings has changed by -$116.05 M (-56.06%)